The StellarexTM drug coated angioplasty balloon (DCB) platform is designed to treat peripheral arterial disease (download PDF brochure). Stellarex uses EnduraCoatTM technology, a durable, uniform coating designed to prevent drug loss during transit and facilitate controlled, efficient drug delivery to the treatment site. The Stellarex DCB platform received CE mark to be marketed in the European Union in December 2014. It is not approved in the United States.
Instructions for Use >